pIpC was injected at 3 weeks post-transplantation to delete Phf6 when CD3+ cells in GFP+ cells were above 70% in JAK3M511I-induced T-cell leukemia (Fig. 3A, B). The gene discussed is PHF6; the disease is T-cell leukemia.